Novel interferon-λs induce antiproliferative effects in neuroendocrine tumor cells

This publication has 26 references indexed in Scilit:

• Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1
  Gut, 2006
• Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-α in hepatocellular carcinoma cell lines
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
• SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29
  Biochemical and Biophysical Research Communications, 2005
• Enhanced expression of suppressor of cytokine signalling‐1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy
  Journal of Viral Hepatitis, 2005
• SOCS-1 and SOCS-3 inhibit IFN-α-induced expression of the antiviral proteins 2,5-OAS and MxA
  Biochemical and Biophysical Research Communications, 2004
• Role of the Interleukin (IL)-28 Receptor Tyrosine Residues for Antiviral and Antiproliferative Activity of IL-29/Interferon-λ1
  Journal of Biological Chemistry, 2004
• Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
  Neuroendocrinology, 2004
• Mechanisms of Interferon-alpha induced apoptosis in malignant cells
  Oncogene, 2002
• Interferon in the Management of Neuroendocrine GEP-Tumors
  Digestion, 2000
• IFNα induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells
  Oncogene, 1997